Marken taps into UPS' global network for new hybrid clinical trials service

By Melissa Fassbender

- Last updated on GMT

Marken is a wholly owned subsidiary of UPS. (Image: iStock/anyaberkut)
Marken is a wholly owned subsidiary of UPS. (Image: iStock/anyaberkut)
Marken has launched a new hybrid logistics service that leverages UPS’ existing global transportation network – including airports, pilots, and aircraft.

Christine Noble, a Marken spokesperson, told Outsourcing-Pharma.com the hybrid logistics service is an alternative to the classic courier shipping model using commercial airlines.

The new hybrid model utilizes the UPS global transportation network which includes 237 owned + 420 leased jet aircraft and 5,000 pilots serving over 680 airports worldwide​,” she explained.

Hybrid models are most appropriately used in conjunction with Marken’s existing partners when turnaround time is a key component of the particular shipment, for either the beginning or end of the shipment’s journey​,” Noble added.

According to the company, the new service provides tighter control to accelerate turnaround time and includes Marken oversight and management.

The hybrid model will be utilized for lanes where this solution will be appropriate to drive enhanced quality through improved turnaround time ​(TAT), or to drive potential savings when situations call for that type of solution to be applicable​,” Noble explained.

The company has also developed a reverse logistics hybrid service for the return of re-useable packaging and tracking devices. 

Marken and UPS – which acquired Marken​ late last year – will continue collaborating to develop additional services and supply chain, Noble said. “Both organizations continue to exhibit great enthusiasm as we continue to serve our clients such CROs, CMOs, and central laboratories​,” she added.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Content provided by Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Follow us

Products

View more

Webinars